Full Text
The Full Text of this article is available as a PDF (79.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Kowdley K. V., Kaplan M. M. Iron-chelation therapy with oral deferiprone--toxicity or lack of efficacy? N Engl J Med. 1998 Aug 13;339(7):468–469. doi: 10.1056/NEJM199808133390709. [DOI] [PubMed] [Google Scholar]
- Olivieri N. F., Brittenham G. M., Matsui D., Berkovitch M., Blendis L. M., Cameron R. G., McClelland R. A., Liu P. P., Templeton D. M., Koren G. Iron-chelation therapy with oral deferipronein patients with thalassemia major. N Engl J Med. 1995 Apr 6;332(14):918–922. doi: 10.1056/NEJM199504063321404. [DOI] [PubMed] [Google Scholar]
- Olivieri N. F., Brittenham G. M., McLaren C. E., Templeton D. M., Cameron R. G., McClelland R. A., Burt A. D., Fleming K. A. Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. N Engl J Med. 1998 Aug 13;339(7):417–423. doi: 10.1056/NEJM199808133390701. [DOI] [PubMed] [Google Scholar]
- Shuchman M. Secrecy in science: the flock worker's lung investigation. Ann Intern Med. 1998 Aug 15;129(4):341–344. doi: 10.7326/0003-4819-129-4-199808150-00032. [DOI] [PubMed] [Google Scholar]
- Stelfox H. T., Chua G., O'Rourke K., Detsky A. S. Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med. 1998 Jan 8;338(2):101–106. doi: 10.1056/NEJM199801083380206. [DOI] [PubMed] [Google Scholar]